Sila Realty Trust, Inc.
NYSE:SILAREIT - Healthcare Facilities
+$0.02 today
- Market cap
- $1.68B
- Beta
- 0.33
- P/E (TTM)
- 44.2
- EPS (TTM)
- $0.69
- Dividend yield
- 5.28%
Volume 0.98M
Average 0.76M
SILA Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Sila Realty Trust, Inc.NYSE: SILA
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How SILA compares with its peers on the latest reported figures
- SILA's LTM Mar 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for SILA, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
SILASila Realty Trust, Inc. | LTM Mar 2026 | $0 | — | — | 0.0% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding SILA) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for SILA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 172.84M | 179.99M | 189.07M | 186.86M | 197.54M |
| Cost of Revenue | 17.71M | 17.95M | 20.2M | 23.14M | 23.8M |
| Gross Profit | 155.13M | 162.04M | 168.87M | 163.72M | 173.73M |
| Gross Margin | 89.8% | 90.0% | 89.3% | 87.6% | 87.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 21.39M | 22.08M | 23.9M | 25.34M | 20.91M |
| Operating Expenses | 119.4M | 99.28M | 98.19M | 103.1M | 108.82M |
| Depreciation & Amortization | 80.92M | 77.2M | 75.03M | 75.93M | 76.95M |
| EBITDA | 119.76M | 93.3M | 122.18M | 139.8M | 142.85M |
| EBITDA Margin | 69.3% | 51.8% | 64.6% | 74.8% | 72.3% |
| Operating Income | 35.73M | 62.76M | 70.68M | 60.62M | 64.92M |
| Operating Margin | 20.7% | 34.9% | 37.4% | 32.4% | 32.9% |
| Interest Income | 3.11M | 305K | 702K | 4.13M | 0 |
| Interest Expense | 37.63M | 24.08M | 23.11M | 21.22M | 32.79M |
| Other Income / Expenses | (34.52M) | (70.74M) | (46.64M) | (17.96M) | (31.8M) |
| Income Before Tax | 1.22M | (7.98M) | 24.04M | 42.66M | 33.12M |
| Pre-Tax Margin | 0.7% | -4.4% | 12.7% | 22.8% | 16.8% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | 402.66M | (7.98M) | 24.04M | 42.66M | 33.12M |
| Net Margin | 233.0% | -4.4% | 12.7% | 22.8% | 16.8% |
| EPS (Basic) | 7.20 | (0.14) | 0.42 | 0.76 | 0.60 |
| EPS (Diluted) | 7.16 | (0.14) | 0.42 | 0.75 | 0.60 |
| Weighted Avg Shares | 56.07M | 56.33M | 56.8M | 56.23M | 55.01M |
| Weighted Avg Shares (Diluted) | 56.36M | 56.33M | 57.31M | 56.69M | 55.51M |
Sila Realty Trust, Inc.
NYSE:SILA
Intrinsic Alpha fair value
Locked
Current Price
$30.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.